LanssonPharm
About:
LanssonPharm is a pharmaceutical company.
Website: http://www.lanssonpharm.com/
Top Investors: Northern Light Venture Capital, Kington Capital
Description:
LanssonPharm is a developer of innovative pharmaceutical products for neuropsychiatric diseases. They offer drugs that specifically target neurodegenerative diseases such as senile dementia, Parkinson's, schizophrenia, stroke, and other diseases of the central nervous system.
Total Funding Amount:
$2.97M
Estimated Revenue Range:
$50M to $100M
Headquarters Location:
Suzhou, Jiangsu, China
Founded Date:
2018-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2019-01-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai